Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Digital Diabetes Management Market Size By Patient Type (Type 1, Type 2), By Product Type (Devices {Smart Glucose Meters, CGM, Insulin Pumps & Patches, Insulin Pens}, By Device Type [Wearable, Handheld], Services {Diabetes Apps, Software}), By End-Use (Hospitals, Home Settings, Diagnostic Centers & Clinics), Research Report, Country Outlook (China, Japan, India, Australia, South Korea, Malaysia, Indonesia, Thailand, Singapore, Taiwan, Philippines, Vietnam), Price Trends, Growth Prospects, Competitive Industry Share & Forecasts, 2021 - 2027
    Published Date: February 2021   |   Report ID: GR1681   |   Delivery: PDF  Request Free Sample

    Asia Pacific Digital Diabetes Management Market size surpassed USD 2.5 billion in 2020 and is anticipated to expand at a CAGR of 19.5% from 2021 to 2027.

    Digital diabetes management solutions include both devices and services. The digital diabetes management solutions include devices that can be connected through smart phone to management software and apps. This includes both insulin delivery and monitoring devices that can connect with smart phones or apps.

    Asia Pacific Digital Diabetes Devices Market

    Get more details on this report - Request Free Sample PDF

    Continuous technological advancement and increasing number of product launches are the factors contributing to the APAC digital diabetes management industry growth. New technologies in digital diabetes space are allowing individualization of care, as patients can work with their healthcare providers to determine which digital device is best fit for their lifestyle and need. Furthermore, continuous improvement in glucose monitoring technologies is also allowing patients to simultaneously reduce hypoglycaemia and improve glycaemic control.

    Increasing burden of diabetes in the region coupled with increasing awareness about diabetes preventive care are the factors contributing to the market growth. In addition, launch of several government initiatives to curb the diabetes burden is also contributing to the market growth. For instance, in November 2019, the Indian Medical Association (IMA) launched the screening camps and mass awareness programmes to spread awareness about the disease. The campaign includes series of events such as interactive seminars, diabetes screening camps, and mass awareness programs.

    APAC Market, By Product Type

    Smart CGM segment revenue was over USD 950 million in 2020 owing to continuous technological advancements and increasing adoption rate of continuous glucose monitors. CGM devices have become increasingly reliable and have great efficacy in reducing hypoglycemia and time in delivering target glucose range. Incremental progress in CGM technology is moving towards fully functional artificial pancreas. As more data is presented to healthcare providers and patients, immediate feedback to patients is providing better outcome, creating demand for the market.

    APAC Market, By Patient Type

    Type 2 diabetes patient segment is predicted to register a growth of over 19.5% through 2027 due to presence of large type 2 patients in the region. The type 2 diabetes is the most common form of diabetes and it affects 80-90% of all people living with diabetes.

    APAC Market, By End-use

    Homecare settings segment will observe a growth of more than 19.8% till 2027. Increasing awareness about diabetes preventive care coupled with user friendly interface of digital diabetes devices are increasing the demand for homecare devices. Moreover, presence of large geriatric population is also increasing the usage of digital diabetes devices in home settings.

    APAC Market, By Country

    China digital diabetes management market held over 19% revenue share in 2020. According to the International Diabetes Federation, more than 116 million people were living with diabetes in 2019 in China. China held the largest diabetes population in the world with the prevalence rate of 10.9% and majority of it depends heavily upon insulin. Furthermore, with the economic development of country, the cost of diabetes per person has also increased from USD 115.0 in 2010 to USD 936.2 in 2019. Thus, with presence of more than 54 million people with impaired glucose tolerance, the country is expected to maintain its dominant position in Asia Pacific during the forecast period.

    Competitive Market Share

    Few of the established major industry players include Abbott Laboratories, Medtronic Plc, Insulet Corporation, F. Hoffmann-LA Roche Ltd., Dexcom, Inc., Companion Medical, Ypsomed, Tandem Diabetes, and Glooko, Inc., among several others. These players are continuous innovating their product and are involved in technological collaborations to cater to growing patient pool. For instance, in November 2020, Microsoft in China and Novo Nordisk A/s announced the collaboration to develop Chinese-speaking AI chatbot for diabetes patients. The collaboration will improve diabetes knowledge of Chinese people.

    Frequently Asked Question(FAQ) :

    How much revenue did Asia Pacific digital diabetes management market generate in 2020?
    The market for digital diabetes management in APAC reached USD 2.5 billion in 2020 and will grow at a robust 19.5% CAGR through 2027.
    Why are smart CGMs gaining traction in Asia Pacific digital diabetes management landscape?
    Smart CGMs generated over USD 950 million in revenue during 2020 and will witness widespread adoption by 2027 on account of ongoing technological advances.
    How do type-2 diabetes patients impact APAC digital diabetes management segment?
    The market share from type 2 diabetes segment is predicted to register a growth of over 19.5% through 2027 due to presence of large patient pool and geriatric population in the region.
    How is the homecare segment contributing to APAC digital diabetes management sector?
    The Asia Pacific industry share from homecare segment is projected to grow at a CAGR of 19.8% due to the presence of a large geriatric population base.
    Which are the key trends driving China digital diabetes management industry outlook?
    The China market captured around 19% of the regional market share and will witness notable growth owing to the largest diabetes population worldwide.

    Get this research report on Asia Pacific Digital Diabetes Management Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]